以第一作者发表文章20余篇，其中SCI文章2篇;主编著作1部，参与编写著作3部，参与翻译著作1部。

　　1. Zhao Y, et al. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in Shandong Province of China. J Clin Hypertens (Greenwich). 2012 Sep;14(9):637-643.

　　2. Zhao Y, et al. Calpain-calcineurin-nuclear factor signaling and the development of atrial fibrillation in patients with valvular heart disease and diabetes. J Diabetes Res. 2016; 2016: 4639654. doi: 10.1155/2016/4639654.

　　3. Lu F, Zhao Y, et al. A 48-week study of amlodipine plus amiloride / hydrochlorothiazide vs. amlodipine plus telmisartan in the treatment of hypertension. Int J Clin Pract. 2012 Aug;66(8):792-799.

　　4. Wang JC, Zhao Y, et al. Proteolysis by endogenous calpain I leads to the activation of calcineurin in human heart. Clin Lab. 2012;58(11-12):1145-1152.

　　5. Sun H, Zhao Y, et al. Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats. Diagn Pathol. 2015 Apr 2;10:18. doi: 10.1186/s13000-015-0246-8.

　　6. Ma L, Wang W, Zhao Y, et al. Combination of Amlodipine plus Angiotensin Receptor Blocker or Diuretics in High-Risk Hypertensive Patients: A 96-Week Efficacy and Safety Study. Am J Cardiovasc Drugs. 2012 Apr 1;12(2):137-42.

　　7. Yong Zhao, et al. Relationship of calcineurin expression between T-lymphocyte and myocardium in patients with heart failure. Journal of Geriatric Cardiology [老年心脏病学杂志(英文版)]. 2010; 07(2): 93-96.

　　8. 王建春, 赵勇, 等. 钙调神经磷酸酶在人类心肌中的表达与分布. 中华心血管病杂志 2008; 36(4): 332-336.

　　9. 张庆, 王建春, 赵勇, 等. 钙蛋白酶-2和钙调神经磷酸酶蛋白表达与瓣膜性心房颤动发生的关系. 中华心血管病杂志. 2015, 43(8): 705-8.